1. Home
  2. ADMA vs SM Comparison

ADMA vs SM Comparison

Compare ADMA & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • SM
  • Stock Information
  • Founded
  • ADMA 2004
  • SM 1908
  • Country
  • ADMA United States
  • SM United States
  • Employees
  • ADMA N/A
  • SM N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • SM Oil & Gas Production
  • Sector
  • ADMA Health Care
  • SM Energy
  • Exchange
  • ADMA Nasdaq
  • SM Nasdaq
  • Market Cap
  • ADMA 3.7B
  • SM 3.0B
  • IPO Year
  • ADMA N/A
  • SM 1992
  • Fundamental
  • Price
  • ADMA $14.50
  • SM $25.24
  • Analyst Decision
  • ADMA Strong Buy
  • SM Hold
  • Analyst Count
  • ADMA 3
  • SM 11
  • Target Price
  • ADMA $27.67
  • SM $42.44
  • AVG Volume (30 Days)
  • ADMA 3.4M
  • SM 2.2M
  • Earning Date
  • ADMA 11-06-2025
  • SM 10-30-2025
  • Dividend Yield
  • ADMA N/A
  • SM 3.18%
  • EPS Growth
  • ADMA 469.09
  • SM 1.83
  • EPS
  • ADMA 0.85
  • SM 7.07
  • Revenue
  • ADMA $474,174,000.00
  • SM $3,002,621,000.00
  • Revenue This Year
  • ADMA $21.17
  • SM $33.13
  • Revenue Next Year
  • ADMA $26.03
  • SM N/A
  • P/E Ratio
  • ADMA $17.31
  • SM $3.56
  • Revenue Growth
  • ADMA 43.58
  • SM 27.02
  • 52 Week Low
  • ADMA $13.50
  • SM $19.67
  • 52 Week High
  • ADMA $25.67
  • SM $46.42
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 30.18
  • SM 42.20
  • Support Level
  • ADMA $14.43
  • SM $24.64
  • Resistance Level
  • ADMA $15.38
  • SM $26.41
  • Average True Range (ATR)
  • ADMA 0.48
  • SM 1.11
  • MACD
  • ADMA -0.10
  • SM -0.15
  • Stochastic Oscillator
  • ADMA 3.57
  • SM 9.73

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About SM SM Energy Company

SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.

Share on Social Networks: